pharmafield logo - pharma news

Weekly news round-up

Pf Web Editor Di Spencer sums up the week's most pertinent stories.
pharmafield logo - pharma news

The Editor’s blog, part 2

Recent reports of the death of NICE are greatly exaggerated. Its power to decide which medicines the NHS can use may well be curbed...
pharmafield logo - pharma news

Weekly news round-up

Pf Web Editor Di Spencer sums up the week's most pertinent stories.
pharmafield logo - pharma news

Top pharma publisher offers Christmas prize draw!

Pf publisher Health Sector Publishing (HSP) is offering one lucky person a free Virgin Experience Day voucher – just for registering on www.pharmafield.co.uk.
pharmafield logo - pharma news

What’s really changed?

Our Industry Insider explains why some change may not be a bad thing.
pharmafield logo - pharma news

It’s beginning to look a lot like Christmas

Is the Christmas season stressing you out?
pharmafield logo - pharma news

The Editor’s blog

Pf Editor Chris Ross takes a look at the White Paper.
pharmafield logo - pharma news

Weekly news round-up

Pf Web Editor Di Spencer sums up the week's most pertinent stories.
pharmafield logo - pharma news

How’s your account management?

Is pharma getting account management right?
pharmafield logo - pharma news

Outcomes – the new targets

Are outcomes the new targets? Di Spencer, Pf Web Editor, explores.

Latest articles

Men's Health Week - 'Lets Talk About the Hard Things' campaign

Men’s Health Week – ‘Lets Talk About the Hard Things’ campaign

This week is Men’s Health Week 2021, a time to not only raise awareness of health conditions but also focus on treatment side effects,...
From porsches to pacemakers: what healthcare can learn from automotive supply chains

From porsches to pacemakers: what healthcare can learn from automotive supply chains

How can automotive supply chains improve healthcare logistics? James Wells, UK International Freight Manager at Aramex explores the transferable practices that automotive manufacturers follow,...
NICE approves Bristol Myers Squibb’s immunotherapy combination

NICE approves Bristol Myers Squibb’s immunotherapy combination

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Document (FAD) recommending the combination of Opdivo® (nivolumab) plus Yervoy®...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Men's Health Week - 'Lets Talk About the Hard Things' campaign

Men’s Health Week – ‘Lets Talk About the Hard Things’ campaign

This week is Men’s Health Week 2021, a time to not only raise awareness of health conditions but also focus on treatment side effects,...
NICE approves Bristol Myers Squibb’s immunotherapy combination

NICE approves Bristol Myers Squibb’s immunotherapy combination

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Document (FAD) recommending the combination of Opdivo® (nivolumab) plus Yervoy®...
Pf talks to Simon Nicholson, MD of Organon, the global women's health company

Pf talks to Simon Nicholson, MD of Organon

It is long overdue, but women’s health is finally having its moment in the spotlight and it feels like there could be a big...
Challenges in recruiting during the pandemic

Challenges in recruiting during the pandemic

Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription